Joined Today: 3

GNBT Generex Biotechnology, Stock Message Board

All Messages

GNBT Message Board Home | Join The GNBT Group |

#14: Generex Announces Enrollment of More Than Two Hundred Subjects in Generex Oral-lyn Phase III Trial
TheMachine	September 20, 2008 02:19:20 AM
WORCESTER, Mass., Sept. 16, 2008 (GLOBE NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) (www.generex.com), the leader in drug delivery for metabolic diseases... view message ignore post recommend post

#13: Generex Biotechnology Announces That An Investigators' Meeting Was Recently Held for Its Global Phase III Clinical Trial of Generex Oral-lyn
TheMachine	February 10, 2008 07:30:02 AM
72 Clinical Centers to Participate in Phase III Study WORCESTER, Mass., Feb. 4, 2008 (PRIME NEWSWIRE) -- Generex Biotechnology... view message ignore post recommend post

#12: Generex Biotechnology Receives Regulatory Approval to Initiate Phase III Clinical Trial for Generex Oral-lyn in First of the Global Locations Selected by the Company
TheMachine	January 29, 2008 02:23:40 AM
Ministry of Health of the Ukraine Approves Phase III Protocol GEN084-OL for a Number of Clinical Sites in the Ukraine WORCESTER,... view message ignore post recommend post

#11: Generex Biotechnology Announces Co-Authorship of Publications With Johns Hopkins University and Stallergenes S.A.
TheMachine	January 29, 2008 02:23:10 AM
Studies Demonstrate the Potency of the Company's Immunotherapy Technology Platform as Well as Its Utility in Characterizing Allergy... view message ignore post recommend post

#10: Generex Biotechnology Awarded Patent in Japan For Its Antigen Presentation Technology
TheMachine	January 18, 2008 05:11:48 PM
WORCESTER, Mass., Dec. 18, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today that its wholly owned... view message ignore post recommend post

#9: Generex Biotechnology Receives $400,000 Purchase Order for OTC Products From Middle Eastern Marketing Partner
TheMachine	January 18, 2008 05:11:22 PM
WORCESTER, Mass., Dec. 13, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for... view message ignore post recommend post

#8: Generex Biotechnology Announces Generex Oral-lyn Marketing Launch Activities Made by the Company's Marketing and Distribution Licensee in India
NewsBot	January 17, 2008 01:47:35 PM
The Company's Medical and Marketing Teams Making Presentations to Leading Indian Endocrinologists in Closed-Door Meetings in Mumbai, India WORCESTER, Mass., Jan. 17, 2008 (PRIME NEWSWIRE)... view message ignore post recommend post

#7: UPGRADE !
Rocketrade	January 16, 2008 11:31:06 PM
Generex Biotechnology "market outperform"Wednesday, January 16, 2008 9:22:33 AM ETRodman & RenshawNEW YORK, January 16 (newratings.com) - Analysts at Rodman & Renshaw reiterate... view message ignore post recommend post

#6: Generex Biotechnology Makes Presentations At Latin-American Diabetes Congress and the Cuban Diabetes Conference
FastFun	November 20, 2007 10:01:18 PM
Generex Biotechnology Makes Three Podium Presentations and One Poster Presentation WORCESTER, Mass., Nov. 16, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT),... view message ignore post recommend post

#5: Noted Wall Street Analyst Highlights Generex Biotechnology in Report
FastFun	November 20, 2007 09:58:52 PM
WORCESTER, Mass., Nov. 15, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the leader in drug delivery for metabolic diseases through the inner lining of the... view message ignore post recommend post

#4: Generex Biotechnology CEO Featured in Fox Business Channel Interview
FastFun	November 20, 2007 09:58:02 PM
Company Executive Discusses Recent Approval to Sell Generex Oral-lyn in India WORCESTER, Mass., Nov. 8, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT), the... view message ignore post recommend post

#3: First Prostate Cancer Patients Treated in a Phase I Clinical Trial as Part of a Collaboration Between Generex Biotechnology and the Saint Savas Cancer Hospital
FastFun	November 20, 2007 09:56:37 PM
WORCESTER, Mass., Nov. 5, 2007 (PRIME NEWSWIRE) -- Generex Biotechnology Corporation (Nasdaq:GNBT) announced today that the first prostate cancer patients had been treated with its novel... view message ignore post recommend post

#2: Generex Biotechnology Receives Regulatory Approval to Sell Generex Oral-lyn in India
FastFun	November 20, 2007 09:54:48 PM
Generex Oral-lyn Becomes First Non-Injectable Buccal Insulin Approved in India; Generex Enters Into Product Licensing & Distribution Agreement With Indian Pharmaceutical Company Shreya Life... view message ignore post recommend post

#1: GNBT: Generex Biotechnology Granted Patents in Canada and Europe
Jason	March 17, 2007 08:29:32 AM
Company Expands Drug Delivery Platform Patent Portfolio in Canada and EuropeGenerex Biotechnology Corporation (NASDAQ: GNBT stock market forum), the leader in drug delivery for metabolic diseases... view message ignore post recommend post

Group Home | Login if you want to post a message